Thyrocare Technologies Limited (THYROCARE.NS)
INR 999.0
(0.48%)
INR 999.0
(0.48%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 707.6 Million INR | 9.72% |
| 2022 | 644.9 Million INR | -63.39% |
| 2021 | 1.76 Billion INR | 55.67% |
| 2020 | 1.13 Billion INR | 28.0% |
| 2019 | 884 Million INR | 3.83% |
| 2018 | 851.4 Million INR | -8.72% |
| 2017 | 932.75 Million INR | 31.44% |
| 2016 | 709.65 Million INR | 37.0% |
| 2015 | 518 Million INR | 16.01% |
| 2014 | 446.5 Million INR | -3.26% |
| 2013 | 461.56 Million INR | -18.77% |
| 2012 | 568.19 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 266.7 Million INR | 10.34% |
| 2024 Q1 | 241.7 Million INR | 35.94% |
| 2023 Q4 | 177.8 Million INR | 15.83% |
| 2023 Q1 | 173 Million INR | 38.51% |
| 2023 FY | 707.6 Million INR | 9.72% |
| 2023 Q3 | 153.5 Million INR | -24.5% |
| 2023 Q2 | 203.3 Million INR | 17.51% |
| 2022 Q2 | 154.3 Million INR | -28.99% |
| 2022 Q4 | 124.9 Million INR | -15.15% |
| 2022 FY | 644.9 Million INR | -63.39% |
| 2022 Q1 | 217.3 Million INR | 2.31% |
| 2022 Q3 | 147.2 Million INR | -4.6% |
| 2021 Q3 | 215 Million INR | -72.34% |
| 2021 Q2 | 777.3 Million INR | 39.88% |
| 2021 Q1 | 555.7 Million INR | 48.23% |
| 2021 FY | 1.76 Billion INR | 55.67% |
| 2021 Q4 | 212.4 Million INR | -1.21% |
| 2020 Q4 | 374.9 Million INR | 15.75% |
| 2020 FY | 1.13 Billion INR | 28.0% |
| 2020 Q3 | 323.9 Million INR | -24.76% |
| 2020 Q2 | 430.5 Million INR | 18617.39% |
| 2020 Q1 | 2.3 Million INR | 114.38% |
| 2019 FY | 884 Million INR | 3.83% |
| 2019 Q1 | 274.7 Million INR | 68.32% |
| 2019 Q2 | 350.5 Million INR | 27.59% |
| 2019 Q3 | 274.9 Million INR | -21.57% |
| 2019 Q4 | -16 Million INR | -105.82% |
| 2018 Q3 | 201.5 Million INR | -20.23% |
| 2018 FY | 851.4 Million INR | -8.72% |
| 2018 Q2 | 252.6 Million INR | 7.95% |
| 2018 Q1 | 234 Million INR | -6.89% |
| 2018 Q4 | 163.2 Million INR | -19.01% |
| 2017 FY | 932.75 Million INR | 31.44% |
| 2017 Q4 | 251.31 Million INR | 17.07% |
| 2017 Q3 | 214.67 Million INR | -12.94% |
| 2017 Q2 | 246.58 Million INR | 11.99% |
| 2017 Q1 | 220.19 Million INR | 16.2% |
| 2016 Q3 | 153.79 Million INR | -23.98% |
| 2016 Q2 | 202.31 Million INR | 23.34% |
| 2016 Q1 | 164.02 Million INR | 17.72% |
| 2016 Q4 | 189.5 Million INR | 23.22% |
| 2016 FY | 709.65 Million INR | 37.0% |
| 2015 Q4 | 139.33 Million INR | 28.84% |
| 2015 Q2 | 162.36 Million INR | 38.01% |
| 2015 Q1 | 117.64 Million INR | 0.0% |
| 2015 FY | 518 Million INR | 16.01% |
| 2015 Q3 | 108.14 Million INR | -33.39% |
| 2014 FY | 446.5 Million INR | -3.26% |
| 2013 FY | 461.56 Million INR | -18.77% |
| 2012 FY | 568.19 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 568.37 Million INR | -24.496% |
| Dr. Lal PathLabs Limited | 3.57 Billion INR | 80.22% |
| Metropolis Healthcare Limited | 1.27 Billion INR | 44.639% |
| Vijaya Diagnostic Centre Limited | 1.18 Billion INR | 40.45% |
| Vimta Labs Limited | 410.09 Million INR | -72.547% |